Autoinjector labels serve marketing, safety, educational and documentation goals
Schreiner MediPharm develops wrap-around labels for Sweden's SHL Medical
The labeling on drug packaging usually starts out as a simple identifier, but now, for autoinjectors and pen injectors (which are often used by patients themselves), it is possible to meet numerous other business or compliance objective. That is some of the thinking that has gone into demonstration projects for SHL Medical (Nacka Strand, Sweden), part of the SHL Group in that country. SHL collaborated with Schreiner MediPharm (US HQ in Blauvelt, NY) to develop multifunction labels that provide educational and compliance goals to the drug sponsor, as well as a platform for attractive branding. With these types of drug-delivery mechanisms—geared toward patients self-injecting, and carrying them with themselves during the day—the package becomes almost an article of personal adornment.
The injectors shown are SHL’s DAI and Molly devices, which are customized to the drug’s delivery requirements. The Schreiner labels feature an anti-slip varnish to improve gripping, a detachable label part for documentation purposes, and both a hologram (a product security feature) and a QR code that can be connected to additional online information. “The specialty labels make customized branding possible and thus emphasize the manufacturers’ brand presentation. Thanks to integrated features the label adds further value,” said Gene Dul, President of Schreiner MediPharm U.S., in a press statement.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
